Cargando…
The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study
INTRODUCTION: Real-world data on the needs of patients with psoriasis and patient-perceived benefits of apremilast are limited. We report such data from France. METHODS: The multicenter, observational REALIZE study was conducted in real-life clinical practice in France and enrolled patients with mod...
Autores principales: | Jullien, Denis, Richard, Marie-Aleth, Halioua, Bruno, Bessette, Christel, Derancourt, Christian, Bouloc, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196307/ https://www.ncbi.nlm.nih.gov/pubmed/37204608 http://dx.doi.org/10.1007/s13555-023-00933-z |
Ejemplares similares
-
Correction to: The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study
por: Jullien, Denis, et al.
Publicado: (2023) -
Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method
por: Richard, Marie-Aleth, et al.
Publicado: (2022) -
Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort
por: BETTUZZI, Thomas, et al.
Publicado: (2022) -
Pediatric psoriasis treated with apremilast
por: Smith, Rebecca L.
Publicado: (2016) -
Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016)